The natural history of adenocarcinoma of the prostate

Lan M. Thompson; Gerald W. Chodak

doi:10.1002/jcb.240501206

The natural history of adenocarcinoma of the prostate

Lan M. Thompson, Gerald W. Chodak

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

All analysis of the efficiency of therapy for prostate cancer must control for the natural history of the disease. Over the past years, several long‐term series involving several hundred patients have helped to describe the results of untreated disease. In general, most patients will not die of their disease, although approximately half of the patients will develop disease progression within 10 years. Predictors of progression include tumor stage, grade, and ploidy status. © 1992 Wiley‐Liss, Inc.

Original language	English (US)
Pages (from-to)	20-25
Number of pages	6
Journal	Journal of Cellular Biochemistry
Volume	50
Issue number	S16H
DOIs	https://doi.org/10.1002/jcb.240501206
State	Published - 1992
Externally published	Yes

Keywords

expectant management
natural history
prostate cancer

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1002/jcb.240501206

Cite this

@article{3c636c2a8c5c40ba81ffdc182a607b65,

title = "The natural history of adenocarcinoma of the prostate",

abstract = "All analysis of the efficiency of therapy for prostate cancer must control for the natural history of the disease. Over the past years, several long‐term series involving several hundred patients have helped to describe the results of untreated disease. In general, most patients will not die of their disease, although approximately half of the patients will develop disease progression within 10 years. Predictors of progression include tumor stage, grade, and ploidy status. {\textcopyright} 1992 Wiley‐Liss, Inc.",

keywords = "expectant management, natural history, prostate cancer",

author = "Thompson, {Lan M.} and Chodak, {Gerald W.}",

year = "1992",

doi = "10.1002/jcb.240501206",

language = "English (US)",

volume = "50",

pages = "20--25",

journal = "Journal of supramolecular structure and cellular biochemistry",

issn = "0730-2312",

publisher = "Wiley-Liss Inc.",

number = "S16H",

}

TY - JOUR

T1 - The natural history of adenocarcinoma of the prostate

AU - Thompson, Lan M.

AU - Chodak, Gerald W.

PY - 1992

Y1 - 1992

N2 - All analysis of the efficiency of therapy for prostate cancer must control for the natural history of the disease. Over the past years, several long‐term series involving several hundred patients have helped to describe the results of untreated disease. In general, most patients will not die of their disease, although approximately half of the patients will develop disease progression within 10 years. Predictors of progression include tumor stage, grade, and ploidy status. © 1992 Wiley‐Liss, Inc.

AB - All analysis of the efficiency of therapy for prostate cancer must control for the natural history of the disease. Over the past years, several long‐term series involving several hundred patients have helped to describe the results of untreated disease. In general, most patients will not die of their disease, although approximately half of the patients will develop disease progression within 10 years. Predictors of progression include tumor stage, grade, and ploidy status. © 1992 Wiley‐Liss, Inc.

KW - expectant management

KW - natural history

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0027057956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027057956&partnerID=8YFLogxK

U2 - 10.1002/jcb.240501206

DO - 10.1002/jcb.240501206

M3 - Article

AN - SCOPUS:0027057956

VL - 50

SP - 20

EP - 25

JO - Journal of supramolecular structure and cellular biochemistry

JF - Journal of supramolecular structure and cellular biochemistry

SN - 0730-2312

IS - S16H

ER -

The natural history of adenocarcinoma of the prostate

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this